E. coli-induced sepsis |
C5a neutralizing antibody |
Increased survival rate, decreased lung edema and oxygenation |
Stevens et al., 1986; Hangen et al., 1987
|
|
anti-C5a antibody |
Decreased IL-6 level in serum |
Hopken et al., 1996
|
|
C5aR knockout |
Attenuation of NK and NKT cell activation |
Fusakio et al., 2011
|
|
|
Reduced TNF-alpha and IFN-gamma release by NK and NKT cells |
|
|
|
Impaired recruitment of NK and NKT cells to the site of infection |
|
|
|
Increased survival rate |
|
LPS-induced endotoxic shock |
C5a neutralizing antibody |
Attenuated septic parameters |
Smedegard et al., 1989
|
|
C5aR knockout |
Increased circulating IL-23 and IL-17A level |
Van Epps et al., 1990; Bosmann et al., 2012
|
|
|
Increased resistance to endotoxic shock |
|
C5L2 knockout |
Increased serum IL-1beta while decreased survival rate |
Han et al., 2011
|
CLP-induced sepsis |
anti-C5a antibody |
Reduced bacterial colony forming-units while improved respiratory burst |
Czermak et al., 1999; Laudes et al., 2002b; Guo et al., 2003, 2006; Flierl et al., 2008a, 2009; Atefi et al., 2011; Bosmann et al., 2011a
|
|
|
Reduced IL-17F level in serum |
|
|
Attenuated coagulant paremeters |
|
|
Reduced apoptosis of adrenal medulla cell |
|
|
Ameliorated septic encephalopathy |
|
|
Restoration of neutrophil to spontaneous apoptosis Reduced inflammatory mediators' production by cardiomyocytes while attenuation of cardiac dysfunction |
|
|
Restoration of C5aR content on neutrophils |
|
C5aR knockout |
Decreased plasma levels of IL-1beta, IL-6, MIP-2, and MIP-1alpha while increased survival rate |
Rittirsch et al., 2008
|
|
C5aR antagonist |
Improved survival |
Huber-Lang et al., 2002a
|
|
C5aR antibody |
Reduced IL-6 and TNF-alpha production in serum, and bacterial burden while improved survival |
Zahedi et al., 2000
|
|
anti-C5L2 antibody |
Increased serum IL-6 level |
|
|
C5L2 knockout |
Decreased serum levels of IL-1beta, MIP-2, MIP-1alpha, and HMGB1 while improved survival |
Rittirsch et al., 2008; Atefi et al., 2011
|
|
|
Increased pro-inflammatory mediators' production from cardiomyocytes |
|
House dust mite-induced allergic asthma |
C5/C5aR knockout |
Increased IL-23 production by dendritic cells and Th17 cell differentiation and proliferation |
Lajoie et al., 2010
|
|
|
Enhanced airway hyperresponsiveness |
|
|
C5L2 knockout |
Attenuated asthmatic phenotye |
Johswich et al., 2006
|
IgG IC-induced acute lung injury |
C5L2 knockout |
Reduced lung inflammation |
Gerard et al., 2005
|